The Inflation Reduction Act, which Biden signed in 2022, caps out-of-pocket insulin costs at $35 a month for Medicare enrollees. The cap took effect in 2023.
Subscribe to continue reading this article.
Already subscribed? To log in, click here.
Originally Published:
